NICE Board says new method allowing greater weight to be given to severe diseases is working
At today's meeting (25th September 2024) our board has concluded that the new severity modifier is working as intended.
At today's meeting (25th September 2024) our board has concluded that the new severity modifier is working as intended.
NHS Talking Therapies for anxiety and depression services saw record referrals in 2023/24.
NICE has recommended belzutifan for some adults with Von Hippel-Lindau disease, in final draft guidance, which could benefit up to 100 people.
People with adrenal insufficiency should be given an emergency medical kit with potentially life-saving steroid injections, according to our new clinical guideline.
Our annual report and accounts, which summarises our key achievements from April 2023 to March 2024.
We explore how North East and North Cumbria Integrated Care Board used behaviour change techniques to implement our antimicrobial prescribing guideline on acute otitis media.
An insight into one of NICE’s most long-standing collaborative relationships.
NICE's deputy chief executive, Jonathan Benger, talks about our new approach to prioritisation.